Carroll B, Nelson G, Rabanal-Ruiz Y, Kucheryavenko O, Dunhill-Turner NA, Chesterman CC, Zahari Q, Zhang T, Conduit SE, Mitchell CA, Maddocks ODK, Lovat P, von Zglinicki T, Korolchuk VI (2017).
Persistent mTORC1 signaling in cell senescence results in defects in amino acid and growth factor sensing.
J Cell Biol. 216(7):1949-1957
Hill D, Lovat P (2017)
Cover Image: Invasion of a cutaneous melanoma tumour.
Br J Dermatol177(2):599
Tang DY, Ellis RA, Lovat PE (2016)
Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma.
Front Oncol. 2016 Nov 9;6:236. Review.
Hernandez-Tiedra S, Fabrias G, Davila D, Salanueva IJ, Casas J, Montes LR, Anton Z, Taboda EG, Slazar M, Lorente M, Nylandsted J, Armstrong JL, Lopez-Valero V, McKee CS, Puebla AS, Lopez RG, Martinez JG, Abad JL, Hanada K, Boya P, Goni FM, Guzman M, Lovat PE, Jaattela M, Alonso A, Velasco G (2016)
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilisation
McConnell AT, Ellis R, Pathy B, Plummer R, Lovat PE, O’Boyle G (2016)
The prognostic significance and impact of the CXCR4/CXCR7/CXCL12 axis in primary cutaneous melanoma.
Br J Dermatol175:1210-1220
Klionsky DJ, et al (Lovat PE author) (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy 12(1):1-222
Hill DS, Robinson ND, Caley MP, Chen M, O’Toole EA, Armstrong JL, Przyborski S, Lovat PE (2015)
A novel fully-humanised 3D skin equivalent to model early melanoma invasion.
Molecular Cancer Therapeutics14: 2665-73
Armstrong JL, Hill DS, McKee C, Hernandez-Tiedra S, Lorenta M, Lopez-Valero I, Anagnostou M, Babatunde F, Redfern CPF, Corazzari M, Velasco G and Lovat PE (2015)
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death
Journal of Investigative Dermatology135: 1629-1637(Impact factor 7.2)
Giglio P, Fimia GM, Lovat PE, Piacentini M and Corazzari M (2015): Review
Fateful music from a talented orchestra with a wicked conductor: Oncogenic BRAF, ER stress and autophagy connection in human melanoma
Molecular and Cellular Oncology26;2(3):e995016

Corazzari M, Rapino F, Ciccosanti F, Antonioli M, Conti B, Fimia GM, *Lovat PE and *Piacentini M (2015)
Oncogenic BRAF induces a chronic ER stress condition resulting in increased basal autophagy and
apoptosis resistance of cutaneous melanoma
Cell Death and Differentiation22: 946-958
*joint senior authors

Hill DS, Haass NK*, Lovat PE* (2014): Review
Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?
Melanoma Management1: 127-137
*joint senior authors

Ellis RA, Horswell S, Ness T, Lumsdon J, Tooze SA, Kirkham N, Armstrong JL and Lovat PE (2014)
Prognostic impact of p62 expression in cutaneous malignant melanoma
Journal of Investigative Dermatology: 134:1476-8 (impact factor 7.2)

Verykiou S, Ellis RA and Lovat PE (2014): Review
Established and emerging biomarkers in cutaneous melanoma
Healthcare 2: 60-73

Corazzari M, Fimia GM, Lovat PE* and Piacentini M* (2013): Review
Why is autophagy important in melanoma? Molecular mechanisms and therapeutic implications
Seminars in Cancer Biology 23: 337-43
*joint senior authors

Corazzari M, Lovat PE (2013): Review
Harnessing autophagy for melanoma benefit
Cell Biology: Research and Therapy2: 1-3

AMLo Biosciences Limited is a company registered in England and Wales. Company # 11004534

Trading address: Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, United Kingdom

Registered address: c/o RMT Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle upon Tyne, NE12 8EG, United Kingdom

VAT # 285288950

Sign up for our newsletter